CAS: 315224-26-1

INT 131 is an estrogen receptor modulator that has been shown to have a proton-pump inhibitor effect. It has the potential to be used in the treatment of bowel disease, cancer, or diabetes. INT 131 inhibits the growth of colon cancer cells in vitro and in vivo by inducing cell lysis and inhibiting inflammatory cytokines. It also has an inhibitory effect on oral hypoglycemic agents and anti-inflammatory drugs. INT 131 is a drug repositioning candidate with possible applications for treating inflammatory diseases such as inflammatory bowel disease or insulin resistance. INT 131 is a drug repositioning candidate with possible applications for treating inflammatory diseases such as inflammatory bowel disease or insulin resistance.

AMG131 (CHS 131) , is a novel, non-thiazolidinedione (TZD), selective peroxisome proliferator-activated receptor (PPAR)gamma modulator, which can be used for

AMG131